Bionomics Ltd Adr Stock Performance
| BNOX Stock | USD 0.28 0.02 6.67% |
On a scale of 0 to 100, Bionomics holds a performance score of 1. The firm shows a Beta (market volatility) of 1.67, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bionomics will likely underperform. Please check Bionomics' maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Bionomics' price patterns will revert.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Bionomics Ltd ADR are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Bionomics showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | BNOX stock touches 52-week low at 0. amid sharp annual decline - Investing.com | 10/02/2024 |
2 | Bionomics to Present at the ThinkEquity Conference | 10/23/2024 |
3 | Disposition of 100000 shares by Wilson David Ian of Bionomics at 0.2866 subject to Rule 16b-3 | 10/25/2024 |
4 | Bionomics Receives Milestone Payment of AUS1M from Carina Biotech for BNC101Partnered Legacy Oncology Program | 11/04/2024 |
5 | Bionomics to Present at the 2024 CNS Summit | 11/07/2024 |
6 | Bionomics files for 100M mixed securities shelf | 11/18/2024 |
| Begin Period Cash Flow | 12.2 M |
Bionomics |
Bionomics Relative Risk vs. Return Landscape
If you would invest 69.00 in Bionomics Ltd ADR on August 24, 2024 and sell it today you would lose (41.00) from holding Bionomics Ltd ADR or give up 59.42% of portfolio value over 90 days. Bionomics Ltd ADR is currently generating 0.3158% in daily expected returns and assumes 23.1199% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Bionomics, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bionomics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bionomics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bionomics Ltd ADR, and traders can use it to determine the average amount a Bionomics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0137
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BNOX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 23.12 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 1 99% of assets perform better |
Based on monthly moving average Bionomics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bionomics by adding it to a well-diversified portfolio.
Bionomics Fundamentals Growth
Bionomics Stock prices reflect investors' perceptions of the future prospects and financial health of Bionomics, and Bionomics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bionomics Stock performance.
| Return On Equity | -0.78 | ||||
| Return On Asset | -0.4 | ||||
| Operating Margin | 89.10 % | ||||
| Current Valuation | (2.32 M) | ||||
| Shares Outstanding | 19.53 M | ||||
| Price To Book | 0.32 X | ||||
| Price To Sales | 386.72 X | ||||
| Revenue | 20 K | ||||
| Gross Profit | (18.96 M) | ||||
| EBITDA | (9.84 M) | ||||
| Net Income | (15.49 M) | ||||
| Cash And Equivalents | 33.56 M | ||||
| Cash Per Share | 4.46 X | ||||
| Total Debt | 239.62 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 12.46 X | ||||
| Book Value Per Share | 1.32 X | ||||
| Cash Flow From Operations | (9.62 M) | ||||
| Earnings Per Share | (1.19) X | ||||
| Market Capitalization | 5.81 M | ||||
| Total Asset | 27.65 M | ||||
| Retained Earnings | (177.98 M) | ||||
| Working Capital | 9.36 M | ||||
About Bionomics Performance
Evaluating Bionomics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Bionomics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bionomics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (13.75) | (14.43) | |
| Return On Tangible Assets | -1.1 K | -1.1 K | |
| Return On Capital Employed | (751.15) | (713.59) | |
| Return On Assets | (560.31) | (532.30) | |
| Return On Equity | (885.75) | (841.47) |
Things to note about Bionomics ADR performance evaluation
Checking the ongoing alerts about Bionomics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bionomics ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bionomics ADR had very high historical volatility over the last 90 days | |
| Bionomics ADR has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 20 K. Net Loss for the year was (15.49 M) with loss before overhead, payroll, taxes, and interest of (18.96 M). | |
| Bionomics Ltd ADR currently holds about 33.56 M in cash with (9.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.46, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Bionomics ADR has a poor financial position based on the latest SEC disclosures | |
| Roughly 34.0% of the company shares are held by company insiders | |
| Latest headline from seekingalpha.com: Bionomics files for 100M mixed securities shelf |
- Analyzing Bionomics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bionomics' stock is overvalued or undervalued compared to its peers.
- Examining Bionomics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bionomics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bionomics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bionomics' stock. These opinions can provide insight into Bionomics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Bionomics Stock Analysis
When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.